BSE Live
Oct 21, 14:55Prev. Close
217.35
Open Price
218.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 21, 14:57Prev. Close
217.26
Open Price
219.48
Bid Price (Qty.)
221.53 (188)
Offer Price (Qty.)
0.00 (0)
Cash Flow of Jagsonpal Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 69.86 | 29.87 | 34.81 | 27.32 | 21.87 | |
Net CashFlow From Operating Activities | 55.30 | 35.17 | 46.66 | 5.60 | 28.22 | |
Net Cash Used In Investing Activities | -45.15 | -24.55 | -57.67 | -26.21 | -2.26 | |
Net Cash Used From Financing Activities | -11.70 | -8.91 | -0.46 | -12.30 | -6.83 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | -1.55 | 1.71 | -11.47 | -32.91 | 19.13 | |
Cash And Cash Equivalents Begin of Year | 12.76 | 11.05 | 22.53 | 58.94 | 39.81 | |
Cash And Cash Equivalents End Of Year | 11.22 | 12.76 | 11.05 | 26.03 | 58.94 |
05.09.2025
28.07.2025
JagsonpalPharma Standalone June 2025 Net Sales at Rs 75.61 crore, up 23.07% Y-o-Y
09.07.2025
07.05.2025
JagsonpalPharma Standalone March 2025 Net Sales at Rs 58.56 crore, up 34.66% Y-o-Y
28.07.2025
JagsonpalPharma Standalone June 2025 Net Sales at Rs 75.61 crore, up 23.07% Y-o-Y
07.05.2025
JagsonpalPharma Standalone March 2025 Net Sales at Rs 58.56 crore, up 34.66% Y-o-Y
24.01.2025
JagsonpalPharma Standalone December 2024 Net Sales at Rs 74.03 crore, up 56.72% Y-o-Y
25.10.2024
JagsonpalPharma Standalone September 2024 Net Sales at Rs 74.69 crore, up 29.16% Y-o-Y